Results for tag: "Aplastic Anemia Drug"

Aplastic Anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough new blood cells. Treatment for Aplastic Anemia includes blood transfusions, immunosuppressive therapy, and hematopoietic stem cell transplantation. Hematological drugs are used to treat Aplastic Anemia, including antithymocyte globulin, cyclosporine, and eltrombopag. These drugs are used to suppress the immune system, stimulate the production of new blood cells, and reduce the risk of infection. The Aplastic Anemia Drug market is a specialized segment of the larger Hematological Drugs market. It is composed of a range of drugs used to treat Aplastic Anemia, including antithymocyte globulin, cyclosporine, and eltrombopag. These drugs are used to suppress the immune system, stimulate the production of new blood cells, and reduce the risk of infection. Some companies in the Aplastic Anemia Drug market include Novartis, Pfizer, GlaxoSmithKline, Merck, and Bristol-Myers Squibb. Show Less Read more